MARFIA, GIROLAMA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 44.165
EU - Europa 7.451
AS - Asia 2.463
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
AF - Africa 5
Totale 54.147
Nazione #
US - Stati Uniti d'America 44.115
IT - Italia 4.362
SG - Singapore 1.161
KR - Corea 674
IE - Irlanda 610
DE - Germania 533
UA - Ucraina 530
CN - Cina 462
RU - Federazione Russa 335
GB - Regno Unito 248
FR - Francia 230
SE - Svezia 199
FI - Finlandia 126
PL - Polonia 81
NL - Olanda 63
CA - Canada 45
IN - India 43
JP - Giappone 40
CH - Svizzera 27
BE - Belgio 23
RO - Romania 21
BR - Brasile 18
CZ - Repubblica Ceca 16
IR - Iran 16
EU - Europa 13
ES - Italia 12
HK - Hong Kong 11
AU - Australia 10
CL - Cile 10
VN - Vietnam 9
GR - Grecia 8
KG - Kirghizistan 8
TR - Turchia 8
UZ - Uzbekistan 8
AT - Austria 7
HR - Croazia 7
A2 - ???statistics.table.value.countryCode.A2??? 5
NO - Norvegia 5
MX - Messico 4
BD - Bangladesh 3
PH - Filippine 3
ZA - Sudafrica 3
AR - Argentina 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ID - Indonesia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
EC - Ecuador 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SM - San Marino 1
Totale 54.147
Città #
Wilmington 12.616
Woodbridge 11.566
Houston 11.554
Fairfield 1.166
Singapore 1.000
Chandler 878
Ann Arbor 802
Dublin 558
Rome 515
Ashburn 498
Seattle 452
Cambridge 435
Medford 375
Jacksonville 367
New York 323
Dearborn 318
Milan 315
Santa Clara 262
Lawrence 176
Beijing 164
Bologna 100
Torino 81
Zhengzhou 80
San Diego 77
Moscow 71
Kraków 67
Turin 65
Naples 60
Verona 58
Creede 53
Padova 48
Redwood City 48
Norwalk 44
Menlo Park 43
Mülheim 43
Roebling 43
Trento 38
Palo Alto 36
Piove di Sacco 36
Florence 32
London 32
Seoul 32
Munich 28
Brescia 24
Brussels 22
San Jose 22
Bari 21
Mcallen 21
Nanjing 21
Palermo 21
Bergamo 20
Falls Church 19
Hefei 19
Mountain View 19
Ottawa 19
Cagliari 18
Kunming 18
Rimini 18
Boardman 17
Messina 17
Busto Arsizio 16
Genoa 16
Helsinki 16
San Genesio Ed Uniti 16
Shanghai 16
Dallas 15
Guangzhou 15
Lappeenranta 15
Lucca 15
Council Bluffs 14
Engelhard 14
Monza 14
Pavia 14
Saint Petersburg 14
Trieste 14
Atlanta 13
Catania 13
Chieti 13
Perugia 13
San Nicola la Strada 13
Ancona 12
Burano 12
Detroit 12
Kilburn 12
Nanchang 12
Parma 12
Salerno 12
Brno 11
Carugate 11
Frankfurt am Main 11
Giarre 11
Jinan 11
Lodi 11
Nishi 11
Pomezia 11
San Mateo 11
Vicenza 11
Bolzano 10
Foggia 10
Modena 10
Totale 46.404
Nome #
Batteria per la valutazione del Deterioramento Mentale (parte II): standardizzazione e affidabilità diagnostica nell’identificazione di pazienti affetti da sindrome demenziale 2.112
Batteria per la valutazione del Deterioramento Mentale (parte I): descrizione di uno strumento di diagnosi neuropsicologica 2.077
Batteria per la valutazione del Deterioramento Mentale (parte III): analisi dei profili qualitativi di compromissione cognitiva 845
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. 573
Neurophysiology of synaptic functioning in multiple sclerosis 513
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 510
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 463
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 456
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 455
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 453
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 452
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 448
Brain MR diffusion tensor imaging in Kennedy's disease 439
Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials 438
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 436
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 431
Synaptic transmission in the striatum: from plasticity to neurodegeneration 423
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 422
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 420
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 420
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 418
Perceptual and conceptual components in implicit and explicit stem completion 414
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 410
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 410
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 409
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 405
Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset,Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis 405
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 402
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 402
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 401
Intestinal pseudobstruction as presenting event of fatal cerivastatin-induced myopathy 401
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 400
Italian multicentre study of peroneal mononeuropathy: multiperspective follow-up 399
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 397
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 395
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 395
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 394
Posterior cortical atrophy with unilateral occipito-temporal degeneration 393
Acute demyelinating sensorimotor polyneuropathy in B-cell lymphoma with IGM autoantibodies against glycolipid GD1B 392
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 389
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease. 389
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 389
INSULIN AUTOIMMUNE SYNDROME (HIRATA DISEASE) RELATED TO THE ALPHA-LIPOIC ACID ASSUMPTION: CASE REPORT AND REVIEW OF THE LITERATURE 388
Explicit memory and repetition priming in dementia: evidence for a common basic mechanism underlying conscious and unconscious retrieval deficits 385
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 383
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 383
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 380
Recency effect in anterograde amnesia: evidence for distinct memory stores underlying enhanced retrieval of terminal items in immediate and delayed recall paradigms 380
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin 379
The autonomic balance predicts cardiac responses after the first dose of fingolimod 376
Glutamate-triggered events inducing corticostriatal long-term depression 374
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 374
Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease 374
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 373
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 372
Lexical and conceptual components of stem completion priming in patients with Alzheimer's disease 371
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 371
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 369
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 368
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 368
Long latency somatosensory evoked potentials: Modifications after percutaneous tibial nerve stimulation 368
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 367
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 367
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 366
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 364
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 364
High sensitivity of autonomic function tests in a case of food-borne botulism 361
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 357
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 356
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 352
Il deterioramento cognitivo nel paziente cerebroleso 350
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 349
The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat corticostriatal slices 348
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 348
Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) 345
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory 344
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 344
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 342
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 339
Neuropatie disimmuni 337
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 337
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 335
Modulation of gene expression following long-term synaptic depression in the striatum 333
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 333
Glutamate-triggered events inducing corticostriatal LTD 332
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 332
Il priming di ripetizione nel deterioramento cognitivo: ipotesi sull’organizzazione della funzione mnesica 331
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 324
Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis 323
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 322
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 321
Relapsing aidp responsive to intravenous immunoglobulin in poems syndrome 318
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 318
Long latency somatosensory evoked potentials: Changes after percutaneous tibial nerve stimulation 318
Corticobulbar And Corticospinal Tract Involvement In Kennedy's Disease 318
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 318
Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings 315
Prevalence of anti-neurofascin-155 and anti-contactin-1 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: a serological multicenter study in Italy 314
AN ITALIAN MULTICENTER DATABASE FOR THE DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) AND ITS VARIANTS: DATA FROM THE FIRST 300 PATIENTS 313
The nerve axon reflex-vasodilation for the assessment of small nerve fibers' dysfunction in diabetic patients 309
Totale 41.895
Categoria #
all - tutte 122.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.169 0 0 0 0 1.181 1.403 1.147 1.156 1.269 1.112 937 964
2020/20219.010 880 963 896 1.127 1.127 961 1.175 885 284 225 357 130
2021/20222.217 144 165 118 187 145 210 134 131 146 185 131 521
2022/20233.426 267 184 314 397 247 618 432 223 282 90 261 111
2023/20241.804 181 65 131 166 144 230 142 127 107 121 89 301
2024/20252.666 232 1.129 640 422 243 0 0 0 0 0 0 0
Totale 55.100